Drug factory · FDA FEI 3002808250

Cerbios-Pharma SA

Via Figino 6, Barbengo/Lugano, Switzerland

Switzerland: 1

Problems found, fixed voluntarily at FDA's last inspection, Mar 7, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

4 drug inspections on record since 2010: 3 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
LeucovorinMakes the active ingredient Hikma Pharmaceuticals USA Inc. 0054-4496, 0054-4497, 0054-4498 +2

FDA inspection history

EndedResultProgramProblems noted
Mar 7, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Apr 27, 2018No problems foundDrug Quality Assurance—
Feb 20, 2014No problems foundDrug Quality Assurance—
Sep 30, 2010No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.